The Impact of Pre-transplant Red Blood Cell Transfusions in Renal Allograft Rejection
Disposition of CommentsProject ID: RENT061-0
The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment (TA) Program supports and is committed to the transparency of its review process. Therefore, invited peer review comments and public review comments are publicly posted on the TA Program Web site at http://www.ahrq.gov/clinic/techix.htm within 3 months after the associated final report is posted.
This document presents the peer review comments and public review comments sent in response to the draft report, The Impact of Pre-transplant Red Blood Cell Transfusions in Renal Allograft Rejection, which was made available for comment on the AHRQ Web site. The final version of the report is available online.
ContentsSelect for Table 1: Invited Peer Reviewer Comments
Select for Table 2: Public Review Comments
Select for Appendix: Public Review Comments Appendix: Response to Amgen
Select for Print version (PDF file, 315 KB). Plugin Software Help.